BSE · 538634
Vasundhara Rasayans Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹36 Cr with net profit ₹4 Cr — a 11.68% net margin, versus 15.04% the period before.
Shareholding
As of 2026-06-30
- Promoter61.98%
- Public38.02%
5,977 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.2× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — ESM · ESM 1. Trading may carry price bands, periodic call auction or higher margins.
Peer comparison
Pharmaceuticals - Indian - Bulk Drugs & Formln · ranked #76 of 102 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | ₹4,77,444 Cr | 38.42 | 5.71 | 13.74% | 19.72% |
| Cipla Ltd. | ₹1,19,101 Cr | 214.6 | 3.46 | 11.27% | 14% |
| Zydus Lifesciences Ltd. | ₹1,11,990 Cr | 20.62 | 4.13 | 18.59% | 18.86% |
| Lupin Limited | ₹1,11,885 Cr | 70.26 | 4.98 | 23.76% | 19.4% |
| Mankind Pharma Limited | ₹1,07,077 Cr | 192.91 | 6.57 | 11.74% | 13.4% |
| Laurus Labs Limited | ₹96,235 Cr | 344.55 | 18.14 | 16.77% | 13.05% |
| Dr Reddys Laboratories Ltd. | ₹95,344 Cr | 431.06 | 2.52 | 0.11% | 0.12% |
| Aurobindo Pharma Ltd. | ₹92,388 Cr | 100.3 | 2.44 | 9.25% | 10.5% |
| Biocon Ltd. | ₹69,837 Cr | 545.38 | 2.05 | 1.14% | 2.3% |
| Alkem Laboratories Ltd. | ₹67,823 Cr | 286.92 | 4.91 | 16.66% | 15.65% |
| Vasundhara Rasayans Ltd.(this company) | ₹55 Cr | 9.5 | 1.35 | 14.16% | 16.32% |
AI analysis
AI-generated · google/gemini-2.5-flashVasundhara Rasayans Ltd., listed with symbol 538634, has a market capitalization of Rs 56 Cr. The company's EPS is Rs 18.22 and its P/E ratio stands at 9.59. The book value per share is Rs 128.62. Annual revenue was Rs 36.34 Cr in Mar 2025, and the profit margin was 16.32%. The stock's 52-week high is Rs 220 and its 52-week low is Rs 100.1.
Positives
- +The debt-to-equity ratio is low at 0.09.
- +Promoter holding is 61.98% as of Mar 2026, indicating significant insider ownership.
- +Return on capital employed (ROCE) was 19.366%.
Negatives
- −Annual revenue decreased by 6.75% from Rs 38.96 Cr in Mar 2024 to Rs 36.34 Cr in Mar 2025.
- −Annual net profit decreased by 27.68% from Rs 5.86 Cr in Mar 2024 to Rs 4.25 Cr in Mar 2025.
- −The company is listed under the ESM · ESM 1 surveillance framework.
- −No DII or FII holding was reported as of Mar 2026.
- −EPS decreased from Rs 18.44 in Mar 2024 to Rs 13.36 in Mar 2025.
Financial performance
Vasundhara Rasayans Ltd. reported annual revenue of Rs 36.34 Cr in Mar 2025, a decrease from Rs 38.96 Cr in Mar 2024. Net profit for Mar 2025 was Rs 4.25 Cr, down from Rs 5.86 Cr in Mar 2024. Quarterly revenue for Mar 2026 was Rs 11.89 Cr, with a net profit of Rs 2.48 Cr. The company's EPS was Rs 13.36 in Mar 2025, compared to Rs 18.44 in Mar 2024.
Profitability & returns
The company’s profit margin was 16.32%. Return on equity (ROE) was 14.16% and return on capital employed (ROCE) was 19.366%. Annual net profit was Rs 4.25 Cr in Mar 2025, down from Rs 5.86 Cr in the preceding year. Quarterly net profit in Mar 2026 was Rs 2.48 Cr, which is the highest in the last four quarters reported.
Balance sheet
Vasundhara Rasayans Ltd. has a debt-to-equity ratio of 0.09, indicating a low level of debt. The book value per share is Rs 128.62. No annual or quarterly balance sheet data on assets or liabilities was provided. Further details on the company's financial structure beyond debt-to-equity are not available in the provided data.
Ownership & pledges
As of Mar 2026, promoters held 61.98% of the shares, while the public held 38.02%. There was no promoter pledge against shares. The number of shareholders was 6006 in Mar 2026. Neither Domestic Institutional Investors (DII) nor Foreign Institutional Investors (FII) held any shares as of Mar 2026, nor were there any institutional holdings.
Regulatory & surveillance
Vasundhara Rasayans Ltd. is under the ESM (Enhanced Surveillance Measure) framework, specifically 'ESM 1'. This indicates that the stock is subject to enhanced monitoring by regulatory authorities, which typically involves additional trading restrictions or reporting requirements to ensure market integrity.
Data as of — price: 2026-07-29 · financials: Mar 25 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.